2023/0131(COD)
Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency
Basic information
2023/0131(COD)
COD - Ordinary legislative procedure (ex-codecision procedure)
Regulation
Repealing Regulation 2000/141
1998/0240(COD)
Repealing Regulation 2004/726
2001/0252(COD)
Repealing Regulation 2006/1901
2004/0217(COD)
Amending Regulation 2007/1394
2005/0227(COD)
Amending Regulation 2014/536
2012/0192(COD)
Subject
4.20.01 Medicine, diseases
4.20.04 Pharmaceutical products and industry
4.60.08 Safety of products and services, product liability
8.40.08 Agencies and bodies of the EU
Legislative priorities
Status
Awaiting Council's 1st reading position
Key players
-
European Parliament
Committee responsible Rapporteur Appointed -
Former committee responsible Former rapporteur Appointed
-
Former committee for opinion Former rapporteur for opinion Appointed BUDGCONTThe committee decided not to give an opinion. ITREVIRKKUNEN Henna (EPP)
05/10/2023
The committee decided not to give an opinion. The committee decided not to give an opinion.
-
-
European Commission
Commission DG Commissioner Health and Food Safety KYRIAKIDES Stella
Key events
Date | Event | Reference | Summary |
---|---|---|---|
26/04/2023 | Legislative proposal published | COM(2023)0193 | |
14/09/2023 | Committee referral announced in Parliament, 1st reading | ||
14/09/2023 | Referral to associated committees announced in Parliament | ||
19/03/2024 | Vote in committee, 1st reading | ||
21/03/2024 | Committee report tabled for plenary, 1st reading | A9-0141/2024 | |
10/04/2024 | Decision by Parliament, 1st reading | T9-0221/2024 | |
10/04/2024 | Results of vote in Parliament | ||
10/04/2024 | Debate in Parliament | ||
13/11/2024 | Committee referral announced in Parliament, 1st reading |
Technical information
Procedure reference | 2023/0131(COD) |
---|---|
Procedure type | COD - Ordinary legislative procedure (ex-codecision procedure) |
Procedure subtype | Legislation |
Legislative instrument | Regulation |
Repealing Regulation 2000/141
1998/0240(COD)
Repealing Regulation 2004/726 2001/0252(COD) Repealing Regulation 2006/1901 2004/0217(COD) Amending Regulation 2007/1394 2005/0227(COD) Amending Regulation 2014/536 2012/0192(COD) |
|
Legal basis | Rules of Procedure EP 57_o Treaty on the Functioning of the EU TFEU 114 Treaty on the Functioning of the EU TFEU 168-p4 |
Other legal basis | Rules of Procedure EP 165 |
Mandatory consultation of other institutions | European Economic and Social Committee European Committee of the Regions |
Stage reached in procedure | Awaiting Council's 1st reading position |
Committee dossier |
ENVI/9/11874
|
Documentation gateway
-
Document type Committee Reference Date Summary Committee draft report PE753.550 20/10/2023 Amendments tabled in committee PE756.138 21/11/2023 Amendments tabled in committee PE756.137 21/11/2023 Amendments tabled in committee PE756.136 21/11/2023 Amendments tabled in committee PE756.134 21/11/2023 Amendments tabled in committee PE756.133 21/11/2023 Amendments tabled in committee PE756.132 21/11/2023 Amendments tabled in committee PE756.131 21/11/2023 Amendments tabled in committee PE756.135 21/11/2023 Amendments tabled in committee PE757.081 30/11/2023 Amendments tabled in committee PE757.080 30/11/2023 Specific opinion AGRI PE757.314 17/01/2024 Committee opinion ITRE PE754.772 22/02/2024 Specific opinion BUDG PE759.054 23/02/2024 Committee report tabled for plenary, 1st reading/single reading A9-0141/2024 21/03/2024 Text adopted by Parliament, 1st reading/single reading T9-0221/2024 10/04/2024 -
Document type Reference Date Summary Document attached to the procedure SWD(2023)0193 26/04/2023 Document attached to the procedure SWD(2023)0192 26/04/2023 Legislative proposal COM(2023)0193 26/04/2023 Document attached to the procedure SWD(2023)0194 26/04/2023 Commission response to text adopted in plenary SP(2024)377 29/07/2024 -
Document type Parliament/Chamber Reference Date Summary Contribution CZ_CHAMBER COM(2023)0193 06/09/2023 Contribution CZ_SENATE COM(2023)0193 10/11/2023 Contribution RO_SENATE COM(2023)0193 20/11/2023 Contribution DE_BUNDESRAT COM(2023)0193 04/12/2023 Contribution IT_SENATE COM(2023)0193 07/12/2023 Contribution FR_SENATE COM(2023)0193 28/10/2024 -
Institution/body Document type Reference Date Summary EDPS Document attached to the procedure N9-0082/2023 OJ C 000 14.11.2023, p. 0000 19/06/2023
Additional information
Source | Document | Date |
---|---|---|
EP Research Service | Briefing | 03/04/2024 |
Transparency
Meetings with interest representatives published in line with the Rules of Procedure
-
Name Role Committee Date Interest representatives WÖLKEN Tiemo Rapporteur ENVI 06/02/2025 The Mission of Japan to the EU WÖLKEN Tiemo Rapporteur ENVI 28/01/2025 Deutsches Netzwerk gegen Antimikrobielle Resistenzen (DNAMR) WÖLKEN Tiemo Rapporteur ENVI 28/01/2025 Permanent Representation of Denmark to the European Union WÖLKEN Tiemo Rapporteur ENVI 27/01/2025 Vertretung des Bundestages in Brüssel WÖLKEN Tiemo Rapporteur ENVI 14/01/2025 European Commission - DG SANTE WÖLKEN Tiemo Rapporteur ENVI 14/01/2025 Permanent Representation of Slovakia to the EU BOSSE Stine Shadow rapporteur ENVI 05/11/2024 European Federation of Pharmaceutical Industries and Associations METZ Tilly Shadow rapporteur ENVI 10/04/2024 Asociación de Sarcomas Grupo Asistencial WÖLKEN Tiemo Rapporteur ENVI 08/04/2024 MEDEV METZ Tilly Shadow rapporteur ENVI 08/04/2024 Standing Committee of European Doctors
-
Name Date Interest representatives JARUBAS Adam 09/07/2024 Chambre de Commerce et d’Industrie France Pologne ECKE Matthias 28/03/2024 European Federation of Pharmaceutical Industries and Associations
GSKKNOTEK Ondřej 20/03/2024 BioMarin UK Limited GUALMINI Elisabetta 19/03/2024 European Confederation of Pharmaceutical Entrepreneurs ZAMBELLI Stefania 13/03/2024 Assosalute GLAVAK Sunčana 29/02/2024 Bayer AG DANZÌ Maria Angela 27/02/2024 European Society of Cardiology LIESE Peter 23/02/2024 European Federation of Pharmaceutical Industries and Associations DANZÌ Maria Angela 21/02/2024 La Roche - Hoffmann SIDL Günther 21/02/2024 AOP Orphan Pharmaceuticals GmbH